Sammy Farah
Vorstandsvorsitzender bei TURNSTONE BIOLOGICS CORP.
Vermögen: - $ am 31.05.2024
Aktive Positionen von Sammy Farah
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TURNSTONE BIOLOGICS CORP. | Direktor/Vorstandsmitglied | 01.10.2015 | - |
| Vorstandsvorsitzender | 01.10.2015 | - | |
| Präsident | 01.10.2015 | - | |
Turnstone Biologics, Inc.
 Turnstone Biologics, Inc. BiotechnologyHealth Technology Turnstone Biologics, Inc. develops bio-therapeutics for the treatment of cancer. It develops Maraba oncolytic viral immunotherapy, a platform representing a disruptive approach in the treatment of cancer. The company was founded by David Stojdl, Brian D. Lichty and John C. Bell and is headquartered in Ottawa, Canada. | Direktor/Vorstandsmitglied | - | - |
| Vorstandsvorsitzender | - | - | |
| Präsident | - | - | |
Myst Therapeutics LLC
 Myst Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Myst Therapeutics LLC develops novel T-cell therapies for solid tumors. The company is based in Glendale, CA. The CEO of the company is Sammy J. Farah. Myst Therapeutics was acquired by Turnstone Biologics, Inc. on January 20, 2021. | Vorstandsvorsitzender | - | - |
Karriereverlauf von Sammy Farah
Ehemalige bekannte Positionen von Sammy Farah
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Synthetic Genomics Vaccines, Inc. | Präsident | 01.09.2011 | 01.10.2015 |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Private-Equity-Analyst | 16.10.2009 | 31.05.2010 |
| IMMUNE DESIGN CORP | Corporate Officer/Principal | 28.07.2010 | - |
Ausbildung von Sammy Farah
| Stanford University | Doctorate Degree |
| University of Pennsylvania | Doctorate Degree |
| Massachusetts Institute of Technology | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 9 |
| Kanada | 2 |
Operativ
| President | 3 |
| Chief Executive Officer | 3 |
| Doctorate Degree | 2 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TURNSTONE BIOLOGICS CORP. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Finance |
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Kenilworth, NJ. | Health Technology |
| Synthetic Genomics Vaccines, Inc. | |
Turnstone Biologics, Inc.
Turnstone Biologics, Inc. BiotechnologyHealth Technology Turnstone Biologics, Inc. develops bio-therapeutics for the treatment of cancer. It develops Maraba oncolytic viral immunotherapy, a platform representing a disruptive approach in the treatment of cancer. The company was founded by David Stojdl, Brian D. Lichty and John C. Bell and is headquartered in Ottawa, Canada. | Health Technology |
Myst Therapeutics LLC
Myst Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Myst Therapeutics LLC develops novel T-cell therapies for solid tumors. The company is based in Glendale, CA. The CEO of the company is Sammy J. Farah. Myst Therapeutics was acquired by Turnstone Biologics, Inc. on January 20, 2021. | Commercial Services |
- Börse
- Insiders
- Sammy Farah
- Erfahrung
